Literature DB >> 3621290

Hypertrophy of pheochromocytoma cells treated with nerve growth factor and activators of adenylate cyclase.

A S Tischler, H Mobtaker, P W Kwan, W J Jason, R A DeLellis, H J Wolfe.   

Abstract

PC12 pheochromocytoma cells treated with nerve growth factor (NGF) in combination with high concentrations of the activators of adenylate cyclase, forskolin or cholera toxin, become more neuron-like in size than cells treated with NGF or with activators of adenylate cyclase alone. Cells treated simultaneously with NGF plus forskolin or cholera toxin paradoxically show less process outgrowth than cells treated with NGF alone. Addition of forskolin or cholera toxin to cells pretreated with NGF, however, produces enlarged cells with intact processes that are indistinguishable from cultured neurons. One possible implication of these findings is that NGF might act in concert with agents that increase intracellular cyclic AMP to cause neuronal maturation during embryogenesis, and that the proper sequence of exposure to these signals is necessary for normal development. Specific activity of acetylcholinesterase is increased by NGF but is unaffected or slightly decreased by forskolin, suggesting that individual aspects of the developing neuronal phenotype are subject to different types of control.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621290     DOI: 10.1007/BF00215430

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  36 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Ultrastructure and in vitro growth characteristics of a transplantable rat pheochromocytoma.

Authors:  R A DeLellis; F B Merk; P Deckers; S Warren; K Balogh
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

3.  Neurofilament protein abnormalities in PC12 cells: comparison with neurofilament proteins of normal cultured rat sympathetic neurons.

Authors:  V M Lee
Journal:  J Neurosci       Date:  1985-11       Impact factor: 6.167

4.  Induction of ornithine decarboxylase by nerve growth factor dissociated from effects on survival and neurite outgrowth.

Authors:  L A Greene; J C McGuire
Journal:  Nature       Date:  1978-11-09       Impact factor: 49.962

5.  Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein.

Authors:  T Spector
Journal:  Anal Biochem       Date:  1978-05       Impact factor: 3.365

6.  Bilateral adrenal medullary hyperplasia in multiple endocrine neoplasia, type 2: the precursor of bilateral pheochromocytoma.

Authors:  J A Carney; G W Sizemore; G M Tyce
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

7.  Regulation of acetylcholinesterase activity by nerve growth factor. Role of transcription and dissociation from effects on proliferation and neurite outgrowth.

Authors:  L A Greene; A Rukenstein
Journal:  J Biol Chem       Date:  1981-06-25       Impact factor: 5.157

8.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

9.  Differential effects of cyclic AMP and cholera toxin on nerve growth factor-induced neurite outgrowth from adrenal medullary chromaffin and pheochromocytoma cells.

Authors:  W Ziegler; K Unsicker
Journal:  Brain Res       Date:  1981-07       Impact factor: 3.252

10.  Synergistic effects of cyclic AMP and nerve growth factor on neurite outgrowth and microtubule stability of PC12 cells.

Authors:  S R Heidemann; H C Joshi; A Schechter; J R Fletcher; M Bothwell
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

View more
  1 in total

1.  Hypertrophy of pheochromocytoma cells treated with nerve growth factor and activators of adenylate cyclase.

Authors:  A S Tischler; H Mobtaker; P W Kwan; W J Jason; R A DeLellis; H J Wolfe
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.